PKC-dependent extracellular signal-regulated kinase 1/2 pathway is involved in the inhibition of Ib on AngiotensinII-induced proliferation of vascular smooth muscle cells

被引:24
作者
Wang, Yu [3 ]
Yan, Tianhua [3 ]
Wang, Qiujuan [3 ]
Wang, Wei [3 ]
Xu, Jinyi [2 ]
Wu, Xiaoming [2 ]
Ji, Hui [1 ]
机构
[1] China Pharmaceut Univ, Dept Pharmacol, Nanjing 210009, Peoples R China
[2] China Pharmaceut Univ, Dept Med Chem, Nanjing 210009, Peoples R China
[3] China Pharmaceut Univ, Dept Physiol, Nanjing 210009, Peoples R China
基金
中国国家自然科学基金;
关键词
Ib; AT(1) receptor antagonist; AngiotensinII; proliferation; protein kinase C; extracellular signal-regulated kinases 1/2;
D O I
10.1016/j.bbrc.2008.07.137
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Angiotensinll (AngII) induces Vascular smooth muscle cell (VSMC) proliferation, which plays an important role in the development and progression of hypertension. Angll-induced cellular events have been implicated, in part, in the activation of protein kinase C (PKC) and extracellular signal-regulated kinases 1/2 (ERK1/2). In the present study, we investigated the effect of lb, a novel nonpeptide Angll receptor type I (AT,) antagonist, on the activation of PKC and ERK1/2 in VSMC proliferation induced by Angll. MTT, and [H-3]thymidine incorporation assay showed that Angll-induced VSMC proliferation was inhibited significantly by lb. The specific binding of [1251]Angll to AT, receptors was blocked by lb in a concentration-dependent manner with IC50 value of 0.96 nM. PKC activity assay and Western blot analysis demonstrated that lb significantly inhibited the activation of PKC and phosphorylation of ERK1/2 induced by Angll, respectively. Furthermore, Angll-induced ERK1/2 activation was obviously blocked by GF109203X, a PKC inhibitor. These findings Suggest that the suppression of lb on Angll-induced VSMC proliferation may be attributed to its inhibitory effect on PKC-dependent ERK1/2 pathway. (C) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:151 / 155
页数:5
相关论文
共 29 条
[2]   Tissue angiotensin and pathobiology of vascular disease - A unifying hypothesis [J].
Dzau, VJ .
HYPERTENSION, 2001, 37 (04) :1047-1052
[3]   Signal transduction of angiotensin II type 1 receptor through receptor tyrosine kinase [J].
Eguchi, S ;
Inagami, T .
REGULATORY PEPTIDES, 2000, 91 (1-3) :13-20
[4]   Protein kinase C delta inhibits the proliferation of vascular smooth muscle cells by suppressing G(1) cyclin expression [J].
Fukumoto, S ;
Nishizawa, Y ;
Hosoi, M ;
Koyama, H ;
Yamakawa, K ;
Ohno, S ;
Morii, H .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (21) :13816-13822
[5]   Mechanisms of smooth muscle contraction [J].
Horowitz, A ;
Menice, CB ;
Laporte, R ;
Morgan, KG .
PHYSIOLOGICAL REVIEWS, 1996, 76 (04) :967-1003
[6]   PROTEIN-KINASE-C ISOENZYMES - DIVERGENCE IN SIGNAL TRANSDUCTION [J].
HUG, H ;
SARRE, TF .
BIOCHEMICAL JOURNAL, 1993, 291 :329-343
[7]   MULTIPLE AUTOCRINE GROWTH-FACTORS MODULATE VASCULAR SMOOTH-MUSCLE CELL-GROWTH RESPONSE TO ANGIOTENSIN-II [J].
ITOH, H ;
MUKOYAMA, M ;
PRATT, RE ;
GIBBONS, GH ;
DZAU, VJ .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 91 (05) :2268-2274
[8]   Isoform-specific protein kinase C activity at variable Ca2+ entry during coronary artery contraction by vasoactive eicosanoids [J].
Kanashiro, CA ;
Khalil, RA .
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 1998, 76 (12) :1110-1119
[9]   Signal transduction by protein kinase mammalian cells [J].
Kanashiro, CA ;
Khalil, RA .
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1998, 25 (12) :974-985
[10]   IN-SITU DETERMINATION OF [CA2+](I) THRESHOLD FOR TRANSLOCATION OF THE ALPHA-PROTEIN KINASE-C ISOFORM [J].
KHALIL, RA ;
LAJOIE, C ;
MORGAN, KG .
AMERICAN JOURNAL OF PHYSIOLOGY, 1994, 266 (06) :C1544-C1551